Haemato-oncology Unit

The Haemato-oncology Unit offers state-of-the-art diagnosis and treatment of all haemato-oncology and lymphatic disorders

The Royal Marsden’s Haemato-oncology Unit is one of the largest in Europe, diagnosing, treating and researching blood cancers in adults and children. The unit runs over 60 clinical trials at any one time and is one of the largest stem cell transplant units in the UK, offering all forms of transplant in both children and adults, as well as various forms of immunotherapy. 

The unit diagnoses and treats a wide range of blood cancers:

  • multiple myeloma
  • acute myeloid leukaemia and myelodysplastic syndrome
  • acute lymphoblastic leukaemia
  • chronic myeloid leukaemia and related disorders
  • chronic lymphocytic leukaemia and related disorders
  • lymphoma (Hodgkin and non-Hodgkin).

How do we diagnose blood cancers?

We use an integrated approach to diagnose blood cancers using multiple tests on blood, bone marrow and lymph node samples. These tests can include:

  • histopathology to look at tissue biopsies at the microscopic level
  • cytogenetics to look for chromosomal changes in cancer cells
  • molecular tests to look for mutations
  • immunophenotyping to look at proteins on the surface of cancer cells
  • PET and MRI scans to stage many lymphomas and myelomas.

Find out more about haematology diagnostics.

How do we treat blood cancers?

Each type of blood cancer requires a different approach. Treatment decisions are made after a careful review of the diagnosis and staging tests at disease-specific multi-disciplinary team meetings.

At these meetings, a range of experts come together to finalise a treatment plan for each individual patient. These experts include pathologists, radiologists, haematologists, medical oncologists, palliative care physicians, specialist nurses and clinical oncologists (doctors who specialise in giving radiotherapy.)

We offer proven treatments including cytotoxic chemotherapy, immunotherapy (such as antibodies that bind to and kill malignant cells), enzyme inhibiting drugs (such as tyrosine kinase inhibitors) and bone marrow transplantation.

Our hospitals in Chelsea and Sutton offer both NHS and private patients inpatient and outpatient care for haemato-oncology cancers, including transplants, chemotherapy and clinical trials.

The Ambulatory Care Service allows some patients undergoing relatively intensive therapies to receive some of their care without needing admission overnight.

Patients staying overnight will normally stay on the Bud Flanagan Wards at our Sutton hospital. In Chelsea, NHS and private patients for chemotherapy and autologous transplants are admitted onto Wiltshaw Ward. No NHS transplants are currently undertaken in Chelsea.


We believe research is one of the key factors in improving patient outcomes. We undertake laboratory-based research to improve our understanding of blood cancers so we can help develop new treatments for acute leukaemia and other disorders. We also work on new ways to improve diagnosis of these diseases.

Clinical trials

The unit runs clinical trials to test new drugs and to find better ways of using established drugs. 

Haemato-oncology Unit staff 

Head of Unit

  • Dr Mark Ethell, Consultant in Haematology and Bone Marrow Transplantation

Myeloma consultants

Chronic lymphoid leukaemias & Lymphomas

Acute leukaemias (AML and ALL)

Transplant consultants

Haematopathology and haematology diagnostics

Associate Specialists

  • Dr Radovan Saso, Associate Specialist in Haematology

Service Manager

  • Christopher Stone

Senior Nursing Team

  • Kim Davis, Haemato-Oncology Research Sister
  • Samantha Wigfall, Matron

Clinical Nurse Specialists/Keyworkers

  • Joy Brennan, Stem Cell Transplant Co-ordinating Sister
  • Maria Mulligan, Stem Cell Transplant Co-ordinator
  • Hayley Leonard, Anthony Nolan Post-Transplant Nurse Specialist
  • Mucha Mupanemunda, Leukaemia Nurse Specialist
  • Sharon West, Haemato-oncology Advanced Nurse Practitioner
  • Carmela (Ella) Panlaqui, Myeloma Nurse Specialist
  • Ewa Kaczmarek, Myeloma Nurse Specialist
  • Tracey Murray, Lymphoma Nurse Specialist
  • Michelle Harris, Lymphoma Nurse Specialist
  • Lucy Whiteman, Lymphoma/CLL Nurse Specialist
  • Viki Hill, Lymphoma Nurse Specialist
  • Kathryn Chandler, Lymphoma Nurse Specialist
  • Jane Howes, Haemato-oncology Clinical Nurse Specialist
  • Janet Baker, Apheresis nurse lead
  • Gemma Findon, Research nurse lead
  • Sarah Thompson, Haemato-oncology Advanced Nurse Practitioner
  • Richard Spencer, Haemato-oncology Advanced Nurse Practitioner

Research Nurses/Key Workers

  • Tommy Brown, Lead Clinical Research Nurse Haemato-oncology
  • John Barwood, Senior Research Nurse - Myeloma
  • Morag Murray, Senior Research Nurse - Lymphoma
  • Karyn Wright, Leukaemia Research Nurse
  • Molly O'Sullivan, Lymphoma Research Nurse
  • Sach P Dissanayakage, Transplant Research Nurse